Abstract
Since recent studies with somatostatin were carefully reviewed by Reichlin (1983) and by a variety of authors in the 2nd International Symposium on Somatostatin, which was held in Athens in 1981 but published with updates in 1984 (Raptis et al., 1984), no attempts are made to cover new developments with somatostatin-14 and somatostatin-28. Instead, this chapter focuses on the recent work in the field of somatostatin analogues and the investigations of their endocrine, gastrointestinal, and antitumor activities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adrian, T. E., Barnes, A. J., Long, R. G., O’Shaughnessy, D. J., Brown, M. R., Rivier, J., Vale, W., Blackburn, A. M., and Bloom, S. R., 1981, The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man, J. Clin. Endocrol. Metab. 53:675–681.
Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T. J., and Pless, J., 1982, SMS-201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action, Life Sci. 31:1133–1140.
Bloom, S. R., Thorner, M. O., Besser, G. M., Hall, R., Gomez-Pan, A., Roy, V. M., Russell, R. C. G., Coy, D. H., Kastin, A. J., and Schally, A. V., 1974, Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone, Lancet 2:1106.
Brown, M. E., Rivier, J. E., and Vale, W. W., 1977, Somatostatin analogs with selected biological activities, Science 196:1467–1468.
Brown, M. P., Coy, D. H., Gomez-Pan, A., Hirst, B. H., Hunter, M., Meyers, C., Reed, J. D., Schally, A. V., and Shaw, B., 1978, Structure-activity relationships of eighteen somatostatin analogues on gastric secretion, J. Physiol. (Lond.) 277:1–14.
Cai, R.-Z., Szoke, B., Fu, D., Redding, T. W., Colaluca, J., Torres-Aleman, I., and Schally, A. V., 1986, in: Proceedings of the Ninth American Peptide Symposium June 1985 (V. J. Hruby, K. D. Kopple, and C. M. Deber, eds.), Pierce Chemical Co., Rockford, II, pp. 627–630.
Charro, A. L., Cabranes, J. A., Lafuente, A., Diaz-Salgado, C., Cordero, M., Almoguera, E., Comaru-Schally, A. M., Meyers, C. A., Coy, D. H., and Schally, A. V., 1984, Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly, Res. Commun. Chem. Pathol. Pharmacol. 45:432–444.
Dembinski, A. B., and Johnson, L. R., 1980, Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin, Endocrinology 106:323–328.
De Quijada, M. G., Redding, T. W., Coy, D. H., Torres-Aleman, I., and Schally, A. V., 1983, Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-releasing hormone and somatostatin, Proc. Natl. Acad. Sci. U.S.A. 80:3485–3488.
Dollinger, H. C., Raptis, S., and Pfeiffer, E. F., 1976, Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man, Horm. Metab. Res. 8:74–78.
Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., and Waterfield, M. D., 1984, Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences, Nature 307:521–527.
Gibbs, J., Young, R. C., and Smith, G. P., 1973, Cholecystokinin elicits satiety in rats with open gastric fistulas, Nature 245:323–325.
Gonzalez-Barcena, D., Mendoza, F., Medina, R., Coy, D. H., Murphy, W. A., and Schally, A. V., 1984, Effect of Ala-2-D-Trp-8-D-Cys-14-somatostatin on the arginine induced release of insulin, GH and glucagon in normal men, Endocrine Res. 10:39–48.
Gottesman, E. S., Mandarino, L. J., and Gerich, J. E., 1982, Somatostatin, in: Special Topics in Endocrinology and Metabolism, Vol. 4 (M. Cohen, ed.), Alan R. Liss, New York, pp. 177–243.
Grant, N., Clark, D., Garsky, V., Juanakais, E., McGregor, W., and Sarantakis, D., 1976, Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats, Life Sci. 19:629–632.
Hall, R., and Gomez-Pan, A., 1976, The hypothalamic regulatory hormones and their clinical applications, Adv. Clin. Chem. 18:173–212.
Heldin, C.-H., and Westermark, B., 1984, Growth factors: Mechanism of action and relation to on-cogenes, Cell 37:9–20.
Hierowski, M. T., Liebow, C., du Sapin, K., and Schally, A. V., 1985, Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line, FEBS Lett. 179:252–256.
Hirst, B. H., Shaw, B., Meyers, C. A., and Coy, D. H., 1980, Structure-activity studies with somatostatin: The role of tryptophan in position 8, Regul. Peptides 1:97–113.
Hirst, B. H., Arilla, E., Coy, D. H., and Shaw, B., 1984, Cyclic hexa-and pentapeptide somatostatin analogues with reduced gastric inhibitory activity, Peptides 5:857–860.
Konturek, S. J., Tasler, J., Krol, R., Dembinski, A., Coy, D. H., and Schally, A. V., 1977, Effect of somatostatin analogs on gastric and pancreatic secretion, Proc. Soc. Exp. Biol. Med. 155:519–522.
Konturek, S. J., Cieszkowski, M., Bilski, J., Konturek, J., Bielanski, W., and Schally, A. V., 1985, Effects of cyclic hexapeptide analog of somatostatin on pancreatic secretion in dogs, Proc. Soc. Exp. Biol. Med. 178:68–72.
Kraenzlin, M. E., Ch’ng, J. C., Wood, S. M., and Bloom, S. R., 1983, Can inhibition of hormone secretion be associated with endocrine tumour shrinkage? Lancet 2:1501.
Kraenzlin, M. E., Ch’ng, J. L. C., Wood, S. M., and Bloom, S. R., 1984, Remission of symptoms and shrinkage of metastasis with long term treatment with somatostatin analogue, Gut 25:A576.
Lamberts, S. W. J., Uitterlinden, P., Zuiderwijk, J., Verleun, T., Neufeld, M., and Del Pozo, E., 1984, The effects of a long-acting somatostatin analog on pituitary tumor growth and hormone secretion in rat and man, Excerpta Med. 652:847.
Long, R. G., Barnes, A. J., Adrian, T. E., Mallinson, C. N., Brown, M. R., Vale, W., Rivier, J. E., Christopides, N. D., and Bloom, S. R., 1979, Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue, Lancet 2:764–767.
Marbach, M., Neufeld, M., and Pless, J., 1984, Clinical applications of somatostatin analogs, in: Proceedings of the Symposium on Somatostatin, Montreal, July 1984 (Y. C. Patel and G. S. Tannenbaum, eds.), Elsevier, Amsterdam, pp. 339–345.
Mascardo, R. N., and Sherline, P., 1982, Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor, Endocrinology 111:1394–1396.
Maton, P. N., O’Dorisio, T. M., Howe, B. A., McArthur, K. E., Howard, J. M., Cherner, J. A., Malarkey, T. B., Collen, M. J., Gardner, J. D., and Jensen, R. T., 1985, Effect of a long-acting somatostatin analogue (SMS 201–995) in a patient with pancreatic cholera, N. Engl. J. Med. 312:17–21.
McCumbee, W. D., McCarty, D. S., Jr., and Lebovitz, H. E., 1980, Hormone responsiveness of a transplantable rat chondrosarcoma. II. Evidence for in vivo hormone dependence, Endocrinology 106:1930–1940.
Merrifield, R. B., 1967, Solid phase peptide synthesis. III. An improved synthesis of bradykinin, Recent Prog. Horm. Res. 23:451–482.
Meyers, C., Arimura, A., Gordin, A., Fernandez-Durango, R., Coy, D. H., Schally, A. V., Drouin, J., Ferland, L., Beaulieu, M., and Labrie, F., 1977, Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release, Biochem. Biophys. Res. Commun. 74:630–636.
Meyers, C. A., Coy, D. H., Huang, W. Y., Schally, A. V., and Redding, T. W., 1978, Highly active position eight analogues of somatostatin and separation of peptide diastereomers by partition chro-matography, Biochemistry 17:2326–2331.
Mortimer, C. H., Tunbridge, W. M. G., Carr, D., Yeomans, L., Lind, T., Coy, D. H., Bloom, S. R., Kastin, A., Mallinson, C. N., Besser, G. M., Schally, A. V., and Hall, R., 1974, Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypo-pituitary patients, Lancet 1:697–701.
Pfeiffer, E. F., and Schusdziarra, V., 1984, What can a clinician extract from the development of somatostatin for therapy? in: 2nd International Symposium on Somatostatin, Athens (Greece) (S. Raptis, J. Rosenthal, and J. E. Gerich, eds.), Attempto Verlag, Tübingen, pp. 222–231.
Plewe, G., Beyer, J., Krause, U., Neufeld, M., and Del Pozo, E., 1984, Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201–995 in acromegaly, Lancet 2:782–784.
Raptis, S., Rosenthal, J., and Gerich, J. E., eds., 1984, 2nd International Symposium on Somatostatin, Athens (Greece), Attempto Verlag, Tübingen.
Redding, T. W., and Schally, A. V., 1983, Inhibition of growth of the transplantable rat chondrosarcoma by analogs of hypothalamic hormones, Proc. Natl. Acad. Sci. U.S.A. 80:1078–1082.
Redding, T. W., and Schally, A. V., 1984, Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones, Proc. Natl. Acad. Sci. U.S.A. 81:248–252.
Redding, T. W., Schally, A. V., Tice, T. R., and Meyers, W. E., 1984, Long-acting delivery systems for peptides: Inhibition of rat prostate tumors by controlled release of [D-Trp-6]luteinizing hormone-releasing hormone from injectable microcapsules, Proc. Natl. Acad. Sci. U.S.A. 81:5845–5848.
Reichlin, S., 1983, Somatostatin, N. Engl. J. Med. 309:1495–1501, 1556–1563.
Rivier, J., Brown, M., and Vale, W., 1975, D-Trp-8-Somatostatin: An analog of somatostatin more potent than the native molecule, Biochem. Biophys. Res. Commun. 65:746–751.
Rivier, J., Brown, M., Rivier, C., Ling, N., and Vale, W., 1977, Hypothalamic hypophysiotropic hormones. Review on the design of synthetic analogs, in: Peptides 1976 (A. Loffet, ed.), l’Université de Bruxelles, Brussels, pp. 427–449.
Rose, D. P., Gottardis, M., and Noonan, J. J., 1983, Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin, Anticancer Res. 3:323–326.
Salomon, D. S., Paglia, L. M., and Verbruggen, L., 1979, Hormone-dependent growth of a rat chondrosarcoma in vivo, Cancer Res. 39:4387–4395.
Schally, A. V., Coy, D. H., and Meyers, C. A., 1978, Hypothalamic regulatory hormones, Annu. Rev. Biochem. 47:89–128.
Schally, A. V., Comaru-Schally, A. M., and Redding, T. W., 1984a, Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers, Proc. Soc. Exp. Biol. Med. 175:259–281.
Schally, A. V., Coy, D. H., Murphy, W. A., Redding, T. W., Comaru-Schally, A. M., Hall, R., Rodriguez-Arnao, M. D., Gomez-Pan, A., Gonzalez-Barcena, D., Millar, R. P., and Konturek, S., 1984b, Physiological and clinical studies with somatostatin analogs and pro-somatostatin, in: 2nd International Symposium on Somatostatin, Athens (Greece) (S. Raptis, J. Rosenthal, and J. E. Gerich, eds.), Attempto Verlag, Tübingen, pp. 188–196.
Schally, A. V., Redding, T. W., and Comaru-Schally, A. M., 1984c, Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms, Cancer Treat. Rep. 68:281–289.
Snodgrass, P. J., 1977, Section 7, Disorders of the pancreas, in: Harrison’s Principles of Internal Medicine, 8th ed. (G. W. Thorn, R. D. Adams, E. Braunwald, K. J. Isselbacher, and R. G. Petersdorf, eds.), McGraw-Hill, New York, pp. 1643–1645.
Szilagyi, G., Irsy, G., Goth, M., Szabolcs, I., Coy, D. H., Comaru-Schally, A. M., and Schally, A. V., 1984, Effect of a somatostatin analogue on trophic hormone levels in acromegalic patients with elevated hGH after adrenomectomy and treatment with bromocriptine, Exp. Clin. Endocrinol. 84:190–196.
Torres-Aleman, I., Redding, T. W., and Schally, A. V., 1985, Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone, Proc. Natl. Acad. Sci. U.S.A. 82:1252–1256.
Townsend, C. M., Jr., Franklin, R. B., Watson, L. C., Glass, E. J., and Thompson, J. C., 1981, Stimulation of pancreatic cancer growth by caerulein and secretin, Surg. Forum 34:228–229.
Usadel, K. H., Leuschner, U., and Uberla, K. K., 1980, Treatment of acute pancreatitis with somatostatin: A multicenter double-blind trial, N. Engl. J. Med. 303:999–1000.
Usadel, K. H., Leuschner, U., and Uberla, K. K., 1984, Report on a randomized double-blind European multicenter study on the use of somatostatin in acute pancreatitis (APTS) in: 2nd International Symposium on Somatostatin, Athens (Greece) (S. Raptis, J. Rosenthal, and J. E. Gerich, eds.), Attempto Verlag, Tübingen, pp. 236–243.
Veber, D. F., Holly, F. W., Nutt, R. F., Bergstrand, S. J., Brady, St. F., Hirschmann, R., Glitzer, M. S., and Saperstein, R., 1979, Highly active cyclic and bicyclic somatostatin analogs of reduced ring size, Nature 280:512–514.
Veber, D. F., Freidinger, R. M., Schwenk-Perlow, D., Paleveda, W. J., Jr., Holly, R. W., Strachan, R. G., Nutt, R. F., Arison, B. H., Homnick, C., Randall, W. C., Glitzer, M. S., Saperstein, R., and Hirschmann, R., 1981, A potent cyclic hexapeptide analogue of somatostatin, Nature 292:55–58.
Veber, D. F., Saperstein, R., Nutt, R. F., Freidinger, R. M., Brady, S. F., Curley, P., Perlow, D. S., Paleveda, W. J., Colton, C. D., Zacchei, A. G., Tocco, D. J., Hoff, D. R., Vandlen, R. L., Gerich, J. E., Hall, L., Mandarino, L., Cordes, E. H., Anderson, P. S., and Hirschmann, R., 1984, A super active cyclic hexapeptide analog of somatostatin, Life Sci. 34:1371–1378.
Von Werder, K., Losa, M., Müller, O. A., Schweiberer, L., Falhbusch, R., and Del Pozo, E., 1984, Treatment of metastasising GRF-producing tumour with a long-acting somatostatin analogue, Lancet 2:282–283.
Wajchenberg, B. L., Cesar, F. P., Lerne, C. E., Borghi, V. C., Souza, I. T. T., Neto, D. G., Germek, O. A., Coy, D. H., Comaru-Schally, A. M., and Schally, A. V., 1983, Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients, Horm. Metab. Res. 15:471–474.
Yamamoto, T., Nishida, T., Miyajima, N., Kawai, S., Ooi, T., and Toyoshima, K., 1983, The erbB gene of avian erythroblastosis virus is a member of the sre gene family, Cell 35:71–78.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Schally, A.V. et al. (1986). Endocrine, Gastrointestinal, and Antitumor Activity of Somatostatin Analogues. In: Moody, T.W. (eds) Neural and Endocrine Peptides and Receptors. GWUMC Department of Biochemistry Annual Spring Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5152-8_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5152-8_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5154-2
Online ISBN: 978-1-4684-5152-8
eBook Packages: Springer Book Archive